Home > Cashflow Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Cash Flow from Financing Activities

    Back to Cashflow Statement
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹1.01 Cr₹-15 Cr₹-44 Cr₹130 Cr₹0.78 Cr

What is the latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH ?

The latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH is ₹1.01 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹1.01 Cr
Mar2024₹-15 Cr
Mar2023₹-44 Cr
Mar2022₹130 Cr
Mar2021₹0.78 Cr

How is Cash Flow from Financing Activities of WINDLAS BIOTECH Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹1.01 Cr
Positive
Mar2024 ₹-15 Cr
Negative
Mar2023 ₹-44 Cr
Negative
Mar2022 ₹130 Cr
16,663.92
Mar2021 ₹0.78 Cr -

Compare Cash Flow from Financing Activities of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,695.3 Cr -8.3% -3.5% -20.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,431.0 Cr -0.4% -0.1% -2% Stock Analytics
DIVIS LABORATORIES ₹163,772.0 Cr 0.9% -3% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,884.0 Cr 2% 1.7% 25.2% Stock Analytics
CIPLA ₹107,503.0 Cr -0.9% -7.2% -9.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,798.0 Cr -0.6% 6.8% 2.7% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-8.3%

-3.5%

-20.4%

SENSEX

-1.1%

-1.2%

5.9%


You may also like the below Video Courses